Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06662279 · ClinicalTrials.gov registry record · NA

Hyrax Vs. Invisalign Palatal Expander Clinical Study

A NA study of Malocclusions and Narrow Maxilla, sponsored by Align Technology.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
4
Study locations

NCT06662279 is a NA study of Malocclusions and Narrow Maxilla that is actively recruiting participants, run by Align Technology. The registered enrollment target is 36 participants. The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06662279, a NA study of Malocclusions and Narrow Maxilla, is actively recruiting participants, sponsored by Align Technology.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to compare expansion result and the overall experience between the Invisalign Palatal Expander and the Hyrax expander.

Interventions

  • DEVICE Removable Rapid Palatal Expander
  • DEVICE Banded Palatal Expander

Study Locations (4)

California

  • Orange Coast Orthodontics - Laguna Hills

Georgia

  • Spillers Orthodontics - Warner Robins

Illinois

  • Innovative Orthodontic Centers - Naperville

Maryland

  • The Orthodontic Studio - Chevy Chase

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2024-10-25
Est. Completion 2026-01
Phase NA

Sponsor

Align Technology

5 total trials

What the Registry Record Tells You About NCT06662279

The ClinicalTrials.gov registry entry for NCT06662279 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Align Technology, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Malocclusions appearing as the primary indexed condition, and to 2 interventions - of which Removable Rapid Palatal Expander is the first listed.

NCT06662279 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Georgia, Illinois.

Frequently Asked Questions

What is clinical trial NCT06662279 about?

NCT06662279 is a clinical study titled "Hyrax Vs. Invisalign Palatal Expander Clinical Study". The purpose of this study is to compare expansion result and the overall experience between the Invisalign Palatal Expander and the Hyrax expander.

What is the current status of trial NCT06662279?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-10-25. Estimated completion is 2026-01.

What conditions does trial NCT06662279 study?

This clinical trial studies the following conditions: Malocclusions, Narrow Maxilla, Narrow Maxillary Arch, Crowding.

What interventions are being tested in trial NCT06662279?

The interventions under investigation include: Removable Rapid Palatal Expander (DEVICE), Banded Palatal Expander (DEVICE).

Who is sponsoring clinical trial NCT06662279?

This trial is sponsored by Align Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06662279 being conducted?

This trial has 4 study locations across California, Georgia, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.